Adeline Péchery

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun et al. · Annals of Oncology · 2022 · 177 citations · Full text

Medicine, Oncology, Radiation Oncology +13

LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial

Jean Bourhis, Clément Sire, Yungan Tao et al. · Annals of Oncology · 2020 · 65 citations

Medicine, Oncology, Radiation Oncology +9

Approach to Oligometastatic Disease in Head and Neck Cancer, on Behalf of the GORTEC

Xu Sun, Cécile Michel, E. Babin et al. · Future Oncology · 2018 · 39 citations

Medicine, Oncology, Radiation Oncology +15

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

Juliette Thariat, Adeline Péchery, Jean Bourhis et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · 21 citations · Full text

Medicine, Oncology, Radiation Oncology +9

Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure

Céline Élie-Caille, Isabelle Lascombe, Adeline Péchery et al. · Molecular and Cellular Biochemistry · 2020 · 20 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14